Sort
15,440 grants matching “organoids”
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
$586,523David M. Ashley · Duke University · U19 · FY2023 · CA
Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer
$586,431Jose M Silva · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Alzheimer's Disease associated pathology induced by neurotropic viral infection
$586,385Eain A Murphy · Upstate Medical University · R01 · FY2024 · AG
New Therapuetics for Pancreatic Cancer
$586,363Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2023 · CA
Estrogen receptor fusions genes as drivers of endocrine resistance in breast cancer
$586,301Adrian Vincent Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Project 1: Mast cell orchestration of epithelial and neuronal responsesÂ
$586,250Ruslan Medzhitov · Food Allergy Science Initiative, Inc. · P01 · FY2024 · AI
Project 1: Mast cell orchestration of epithelial and neuronal responsesÂ
$586,250Ruslan Medzhitov · Food Allergy Science Initiative, Inc. · P01 · FY2025 · AI
Ghrelin as Radiation Countermeasure: Mechanism of Its Action
$586,240Ping Wang · Feinstein Institute For Medical Research · U01 · FY2025 · AI
MYC-regulated RNA Binding Protein Networks and Spliced Isoforms Driving Cancer
$586,166Olga Anczukow-Camarda · Jackson Laboratory · R01 · FY2023 · CA
Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancer
$586,157Humam Kadara · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Investigating the mechanisms of driver genes associated with ancestry and aggressiveness in prostate cancer
$586,110Joshua D Campbell · Boston University Medical Campus · R01 · FY2022 · CA
TP53 SYNTHETIC LETHAL SCREEN IN ORGANOID AVATARS TO DISCOVER NOVEL THERAPEUTIC TARGETS FOR COLON CANCER
$586,000University Of South Carolina · · FY2019 · Defense Health Agency
Single-cell congruence evaluation and selection of cancer models towards precision medicine
$585,931George C. Tseng · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
UCSF Project 1
$585,896Trever G Bivona · University Of California, San Francisco · U54 · FY2019 · CA
Targeting MTOR signaling in pancreatic cancer
$585,758Brian C Lewis · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · CA
Centrosome instability as a mechanism to promote localized prostate cancer
$585,679Gregory Charles Rogers · University Of Arizona · R01 · FY2023 · CA
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
$585,470Jianwen Que · Columbia University Health Sciences · R01 · FY2022 · HL
Synaptic Pruning and Complement Gene in Schizophrenia: Imaging & Cellular Studies
$585,412Konasale M Prasad · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · MH
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$585,317Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2025 · CA
Neuropathogenesis of Errors of Immunity
$585,279Farinaz Safavi · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
$585,212Baohua Zhou · Indiana University Indianapolis · R01 · FY2023 · CA
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
$585,212Baohua Zhou · Indiana University Indianapolis · R01 · FY2025 · CA
Microgial contribution and therapeutic potential in Friedreich's ataxia
$585,180Stephanie Cherqui · University Of California, San Diego · R01 · FY2025 · NS
Elucidating the role of gut microbiota in colitis-associated colorectal cancer
$585,084Ru Chen · Baylor College Of Medicine · R01 · FY2024 · CA
Defining and perturbing gene regulatory dynamics in the developing human brain
$584,776William James Greenleaf · Stanford University · R01 · FY2024 · NS